您当前所在的位置:首页 > 产品中心 > 产品信息
KR-32568_分子结构_CAS_852146-73-7)
点击图片或这里关闭

KR-32568

产品号 K4389 公司名称 Sigma Aldrich
CAS号 852146-73-7 公司网站 http://www.sigmaaldrich.com
分子式 C13H12FN3O2 电 话 1-800-521-8956
分子量 261.2516832 传 真
纯 度 ≥98% (HPLC) 电子邮件
保 存 Chembase数据库ID: 154026

产品价格信息

请登录

产品别名

标题
KR-32568
IUPAC标准名
N-carbamimidoyl-5-(5-fluoro-2-methylphenyl)furan-2-carboxamide
IUPAC传统名
N-carbamimidoyl-5-(5-fluoro-2-methylphenyl)furan-2-carboxamide
别名
[5-(2-Methyl-5-fluorophenyl)furan-2-ylcarbonyl]guanidine

产品登记号

CAS号 852146-73-7
PubChem SID 24724522
MDL号 MFCD08705324

产品性质

Empirical Formula (Hill Notation) C13H12FN3O2
纯度 ≥98% (HPLC)
相关基因信息 human ... SLC9A1(6548)
外观 white solid
溶解度 DMSO: ~10 mg/mL
GHS危险品标识 GHS07
GHS警示词 Warning
GHS危险声明 H302-H315-H319-H335
欧盟危险性物质标志 有害性(Harmful) 有害性(Harmful) (Xn)
MSDS下载 下载链接
个人保护装置 Eyeshields, Faceshields, full-face respirator (US), Gloves, multi-purpose combination respirator cartridge (US), type ABEK (EN14387) respirator filter
GHS警示性声明 P261-P305 + P351 + P338
危险公开号 22-36/37/38
安全公开号 26-36
保存温度 2-8°C
德国WGK号 3

产品详细信息

详细说明 (English)
Biochem/physiol Actions
Sodium/hydrogen exchanger-1 (NHE-1) inhibitor; IC50 = 0.23 μM; inhibited NHE-1-mediated rabbit platelet swelling; in anesthetized rats, reduced infarct size from 67% (control) to 43% (at 0.1 mg/kg) and 24% (at 1.0 mg/kg); reduced number of ventricular premature beats from 530 to 266 (at 0.1 mg/kg) and 115 (at 1.0 mg/kg); reduced ventricular fibrillation incidence from 17 to 8 (0.1 mg/kg) and 0 (1.0 mg/kg); implications for research and treatment of myocardial ischemic diseases.
详细说明 (简体中文)
Biochem/physiol Actions
Sodium/hydrogen exchanger-1 (NHE-1) inhibitor; IC50 = 0.23 μM; inhibited NHE-1-mediated rabbit platelet swelling; in anesthetized rats, reduced infarct size from 67% (control) to 43% (at 0.1 mg/kg) and 24% (at 1.0 mg/kg); reduced number of ventricular premature beats from 530 to 266 (at 0.1 mg/kg) and 115 (at 1.0 mg/kg); reduced ventricular fibrillation incidence from 17 to 8 (0.1 mg/kg) and 0 (1.0 mg/kg); implications for research and treatment of myocardial ischemic diseases.

参考文献